Portman Square Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SOMN
The Southern Company 2025 Series A Corp Units
SOMN
|
+$88.6M |
| 2 |
NextEra Energy
NEE
|
+$32.4M |
| 3 |
Albemarle Corp Depositary Shares
ALB.PRA
|
+$29.3M |
| 4 |
NOVTU
Novanta Inc Units
NOVTU
|
+$21.6M |
| 5 |
KKR & Co
KKR
|
+$15.4M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 1.69% |
| 2 | Technology | 0.97% |
| 3 | Financials | 0.74% |
| 4 | Industrials | 0.72% |
| 5 | Materials | 0.39% |
Similar funds
Portman Square Capital's Q4 2025 Portfolio in Review
As of Q4 2025, Portman Square Capital held 136 positions worth $2.26B, up 0.07% from $2.26B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Portman Square Capital withdrew a net $226M in Q4 2025, closing 19 positions and reducing 26 holdings. Its most notable exit was BridgeBio Pharma, an estimated $7.73M position sold in full.
By sector, the portfolio is most concentrated in Utilities at 1.7% of assets, up from 0% a quarter earlier, followed by Technology and Financials.
Against the trend, Portman Square Capital opened a new position in The Southern Company 2025 Series A Corp Units worth $88.9M.
- Portman Square Capital's largest Q4 2025 buy was The Southern Company 2025 Series A Corp Units: 1,786,000 shares worth $88.9M.
- Portman Square Capital added most to Albemarle Corp Depositary Shares in Q4 2025, an estimated $29.3M increase.
- Portman Square Capital's biggest Q4 2025 reduction was KKR & Co 6.25% Series D Preferred Stock, cutting an estimated $130M.
- Portman Square Capital fully exited BridgeBio Pharma in Q4 2025, selling an estimated $7.73M.
- Portman Square Capital's ten largest holdings make up 43% of its $2.26B portfolio in Q4 2025.
- Portman Square Capital opened 26 new positions and closed 19 in Q4 2025.
- Portman Square Capital's portfolio value rose 0.07% quarter-over-quarter to $2.26B.
Based on Portman Square Capital's 13F filing for Q4 2025, filed 23 Jan 2026.